The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singh, R. A. K.
Right arrow Articles by Zhang, J. Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singh, R. A. K.
Right arrow Articles by Zhang, J. Z.
The Journal of Immunology, 2004, 173: 7299-7307.
Copyright © 2004 by The American Association of Immunologists

Differential Activation of ERK, p38, and JNK Required for Th1 and Th2 Deviation in Myelin-Reactive T Cells Induced by Altered Peptide Ligand1

Rana A. K. Singh* and Jingwu Z. Zhang2,*,{dagger}

* Department of Neurology, Baylor College of Medicine, Houston, TX 77030; and {dagger} Health Science Center, Chinese Academy of Sciences-Shanghai Second Medical University, Shanghai, China

Autoreactive T cells can be induced by altered peptide ligands to switch Th1 and Th2 phenotypes. The underlying molecular mechanism is critical for understanding of activation of autoreactive T cells and development of novel therapeutic strategies for autoimmune conditions. In this study, we demonstrated that analog peptides of an immunodominant epitope of myelin basic protein (residues 83–99) with alanine substitution at Val86 and His88 had a unique partial agonistic property in the induction of Th1 or Th2 deviation in MBP83–99-reactive T cell clones typical of Th0 phenotype. The observed phenotypic switch involved differential activation of ERK, p38, and JNK MAPKs. More specifically, Th1 deviation induced by peptide 86V->A (86A) correlated with enhanced p38 and JNK activities, while Th2 deviation by peptide 88H->A (88A) was associated with up-regulated ERK activity and a basal level of p38 and JNK activity. Further characterization revealed that a specific inhibitor for ERK selectively prevented Th2 deviation of MBP83–99-specific T cells. Conversely, specific inhibitors for p38 and JNK blocked Th1 deviation in the same T cell preparations induced by peptide 86A. The findings have important implications in our understanding of regulation of ERK, p38, and JNK by altered peptide ligands and their role in cytokine regulation and phenotype switch of autoreactive T cells.




This article has been cited by other articles:


Home page
Mult SclerHome page
M. Han and L Steinman
Systems biology for identification of molecular networks in multiple sclerosis
Multiple Sclerosis, May 1, 2009; 15(5): 529 - 530.
[PDF]


Home page
J. Leukoc. Biol.Home page
S. M. Shin, Y. H. Kim, B. K. Choi, P. M. Kwon, H.-W. Lee, and B. S. Kwon
4-1BB triggers IL-13 production from T cells to limit the polarized, Th1-mediated inflammation
J. Leukoc. Biol., June 1, 2007; 81(6): 1455 - 1465.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Viardot, S. T. Grey, F. Mackay, and D. Chisholm
Potential Antiinflammatory Role of Insulin via the Preferential Polarization of Effector T Cells toward a T Helper 2 Phenotype
Endocrinology, January 1, 2007; 148(1): 346 - 353.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
L Xia, L Ru, and L Zhanguo
Altered influenza virus haemagglutinin peptides inhibit T cell responses to type II collagen in rheumatoid arthritis
Ann Rheum Dis, December 1, 2005; 64(12): 1790 - 1791.
[Full Text] [PDF]


Home page
J. Immunol.Home page
P. G. Thomas, M. R. Carter, A. A. Da'dara, T. M. DeSimone, and D. A. Harn
A Helminth Glycan Induces APC Maturation via Alternative NF-{kappa}B Activation Independent of I{kappa}B{alpha} Degradation
J. Immunol., August 15, 2005; 175(4): 2082 - 2090.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.